Marshall, Gerstein & Borun Shortlisted for Three LMG Life Sciences Awards

September 9, 2013

Marshall, Gerstein & Borun LLP is pleased to announce that the Firm has been shortlisted for the LMG Life Sciences Awards this year in the categories of Patent Prosecution: Firm of the Year and Patent Strategy and Management: Team of the Year. Additionally partner David Gass is a finalist for Patent Prosecution: Attorney of the Year (Medical Devices). Winners will be announced at an awards ceremony hosted by LMG Life Sciences on September 25, 2013 at Essex House in New York City.

LMG Life Sciences is the publisher of an annual guide aimed at providing attorneys and law firms with information on the legal market and the U.S. life sciences industry. In the 2013 LMG Life Sciences guide, Marshall Gerstein is highly recommended for patent prosecution and highly recommended for patent strategy and management. Additionally, managing partner Jeffrey Sharp and partner David Gass are recognized as Life Sciences Stars for their outstanding patent work in life sciences. The Firm’s large biotechnology group includes lawyers and patent agents with broad experience in a variety of biotechnology disciplines, including: DNA, RNA, vaccine, protein, and antibody therapeutics and diagnostics; cell-based and viral therapeutics; drug and gene therapy delivery vehicles; plant biotechnology; industrial technology and research platforms; nanotechnology and interdisciplinary inventions.

Offsite Notice

By clicking “Proceed” below, you will be opening a new browser window and leaving our website.